
Keywords: AMN; adrenomyeloneuropathy; cALD; cerebral adrenoleukodystrophy; CNS; central nervous system; DBP; D-bifunctional protein (also called MFP2 and HSD17B4); H&E; hematoxylin & eosin; HSD17B4; 17β-hydroxysteroid dehydrogenase type 4 (also called DBP or MFP2)